Substantial Equivalence Study for Kai Sensors RSpot Non-Contact Respiratory Rate Spot Check
NCT ID: NCT00827905
Last Updated: 2010-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2009-01-31
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Substantial Equivalence Study for Kai Medical Non-Contact Respiratory Rate Monitor
NCT01176539
Respiratory Rate Validation Study
NCT05856422
Validation of Respiratory Rate and Heart Rate Measurements by Capaciflectors Placed in Four Locations on the Chest
NCT03832205
Using Ultrasound to Study Respiratory Muscle Function in Critically Ill Patients
NCT03139695
Impact of Enhanced External Counterpulsation (EECP) on VO2 MAX
NCT02517671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study, the RSpot is operated simultaneously with two other systems that provide a respiratory rate: Welch Allyn Propaq Encore model 242 and Embletta system with Universal XactTrace and Somnologica software. A respiratory rate is also obtained by counting respiratory excursions for the same duration as the RSpot measurement interval, 15, 30, or 60 seconds. The rates obtained from each of the four measurement methods are then compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Hospitalized
Patients admitted to the hospital
RSpot Non-Contact Respiratory Rate Spot Check
The Kai Sensors RSpot 100 provides a measurement of respiratory rate at a single point in time. It uses a low-power radar to detect respiratory effort, and analyzes the respiratory effort signal to provide a respiratory rate.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RSpot Non-Contact Respiratory Rate Spot Check
The Kai Sensors RSpot 100 provides a measurement of respiratory rate at a single point in time. It uses a low-power radar to detect respiratory effort, and analyzes the respiratory effort signal to provide a respiratory rate.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized on Tower 6 or Pauahi 6 or Pauahi 4
* Clinically stable
* Able to provide informed consent
Exclusion Criteria
1. Hypotensive requiring pressors or intra-aortic balloon pump
2. Intubated
3. Dyspnea or chest pain at rest
4. Resting tachycardia (heart rate \>100 bpm)
5. Requires supplemental (e.g., nasal canula or face mask) oxygen
* Scheduled or planned (e.g., CT scan, central line placement) procedure during the 30 minute study period
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kai Medical, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kai Medical, Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Todd Seto, MD
Role: PRINCIPAL_INVESTIGATOR
The Queen's Medical Center
Olga Boric-Lubecke, PhD
Role: STUDY_DIRECTOR
University of Hawaii
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Queen's Medical Center
Honolulu, Hawaii, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RA-2008-061
Identifier Type: -
Identifier Source: secondary_id
KAI-00003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.